Literature DB >> 25360490

Role of cyanate in the induction of vascular dysfunction during uremia: more than protein carbamylation?

Clare L Hawkins1.   

Abstract

Cyanate is a uremic toxin responsible for the carbamylation of proteins, which has been implicated as playing a key role in accelerating the progression of atherosclerosis in patients with chronic kidney disease. El-Gamal et al. report that while cyanate promotes protein carbamylation in vivo, the resulting endothelial dysfunction observed is consistent with reactions mediated by cyanate itself, rather than by carbamylated proteins. This provides new insight into the relationship between uremia and cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25360490     DOI: 10.1038/ki.2014.256

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  3 in total

1.  Constant molecular aging rates vs. the exponential acceleration of mortality.

Authors:  Caleb E Finch; Eileen M Crimmins
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-20       Impact factor: 11.205

2.  Impact of fibrinogen carbamylation on fibrin clot formation and stability.

Authors:  Veronika Binder; Brith Bergum; Stéphane Jaisson; Philippe Gillery; Carsten Scavenius; Endy Spriet; Anne Karin Nyhaug; Helen M Roberts; Iain L C Chapple; Annelie Hellvard; Nicolas Delaleu; Piotr Mydel
Journal:  Thromb Haemost       Date:  2017-04-06       Impact factor: 5.249

3.  Cyanate-Impaired Angiogenesis: Association With Poor Coronary Collateral Growth in Patients With Stable Angina and Chronic Total Occlusion.

Authors:  Jia Teng Sun; Ke Yang; Jing Yan Mao; Wei Feng Shen; Lin Lu; Qi Hong Wu; Yan Ping Wang; Li Ping Wu; Rui Yan Zhang
Journal:  J Am Heart Assoc       Date:  2016-12-16       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.